Subjects were allocated to one of three dose groups ( n = 20 per group ) to receive 10 , 40 or 80 yeast units ( YU ; 1YU = 10 ( 7 ) yeast ) of GS-4774 in two immunization regimens ( five subcutaneous injections at weekly intervals with one monthly booster or three subcutaneous injections at monthly intervals ) .